Elite Academic Academy www.eliteacademic.comis transforming education by equipping teachers, collaborating with families, and tailoring learning to each student's unique path. Elite Academic Academy will be spotlighted on regional PBS stations in an upcoming segment of “All Access with Andy Garcia.” Public television viewers will get an inside look at Elite Academic Academy, a non-profit, non-classroom-based […]

Event raises over $35,000 and awareness about programs and services for individuals with autism This October, theNaperville-based nonprofit Turning Pointe Autism Foundationcelebrated National Disability Employment Awareness Monthwith itsninth annual Pumpkin Race. This community event raised more than $35,000 and welcomed over 350 attendees, including Turning Pointe students and program participants, families and friends of individuals

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Mr. Cooper Group Inc. ("Mr. Cooper" or the "Company") (NASDAQ:COOP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Mr. Cooper and certain of its

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / If you suffered a loss on your Lantheus Holdings, Inc. (NASDAQ:LNTH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lantheus-holdings-inc-lawsuit-submission-form-2?prid=176133&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

SLNO Investors with Losses Encouraged to Contact Hagens Berman On November 5, 2025, investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) saw the price of their shares tumble $18.78 (-28%) after the company reported disappointing information about VYKAT™ XR, a once-daily oral tablet intended to treat hyperphagia. Soleno has described this condition as “the most life-limiting

Klotho Neurosciences, Inc. (NASDAQ: KLTO ) (the “Company” or “Klotho”), a U.S.-based biogenetics company, announces it has been selected as winner of the Fifth Annual BioTech Breakthrough Award in the “Cell Therapy Innovation of the Year” category. https://mma.prnewswire.com/media/2705840/Klotho_Neurosciences_Logo.jpg Klotho Neurosciences earned this recognition for its pioneering work developing transformative gene and cell therapies using a

Plaintiffs' firm honored by “Best Lawyers” in 2026 list highlighting the top 3.8% of law firms nationwide.* The Law Offices of James Scott Farrin is proud to announce that it has been honored by “Best Lawyers” on its 2026 'Best Law Firms' list, a trusted benchmark of legal excellence.* https://mma.prnewswire.com/media/1027985/Law_Offices_of_James_Scott_Farrin_Logo.jpg The firm received a Tier

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Akebia Therapeutics, Inc. ("Akebia" or the "Company") (NASDAQ:AKBA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Akebia and certain of its officers and/or directors

(NYSE:VFC), LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against V.F. Corporation (“VF” or “the Company”) (NYSE: VFC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders

Collaboration will bring Roam's assumable mortgages infrastructure to Opendoor's national home marketplace- Roam, the platform enabling homebuyers to purchase homes with assumable low-rate mortgages, today announced a partnership withOpendoor Technologies, Inc. (“Opendoor”), a leading e-commerce platform for residential real estate transactions. The collaboration will introduce Roam's assumable mortgage tools and transaction support to buyers shopping